Contact 112-3201 Wilson St. Penticton, BC Canada V2A 8J3 cap@pompecanada.com Name Email Address Message Submit Recent Posts Amicus Therapeutics Has Begun the FDA Submission for Their Pompe Drug, AT-GAA New Review Article Highlights Latest Developments in Pompe Disease Research The Genetic Non-Discrimination Act New ERT For Late-onset Pompe Disease Shows Promise 2020 CAP Annual General Meeting Share this:FacebookTwitterLinkedIn
